TGFB1 and neoplasm: Significantly more IFN-γ-expressing CD8+T lymphocytes, elevated levels of IFN-γ and IL-2, fewer CD25+ forkhead box P3 (Foxp3) +Tregs and decreased levels of IL-10 and TGF-β were detected at tumor sites.